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Mu Opioid Receptor Desensitization in Inflammatory Pain
Matthew Bredder, Nicolas Massaly, Adie Wilson-Poe, Jose Moron-Concepcion
Washington University in St. Louis – Department of Anesthesiology – Biology, Psychology Class of 2017
Due to the epidemic level of opioid overdose deaths in the United States, improving the treatment of chronic pain has become a pressing concern. Opioid treatments such as fentanyl
and morphine activate mu opioid receptors (MORs), causing an increase in dopamine release. Long term use of opioids, even as prescribed by a physician, can desensitize the MORs
and lead to the appearance of withdrawal symptoms when the receptors are no longer stimulated. Since pain increases endogenous opioid release, we hypothesized that this increase
may cause MOR desensitization and the appearance of withdrawal syndrome upon blockade of MORs, as seen in long term opioid use.
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Methods

Hypothesis
In Figure A, reduced dopamine
(DA) release in the nucleus
accumbens (NAc) was seen in
the condition of inflammatory
pain when selective MOR
agonist DAMGO was
administered in the ventral
t e g m e n t a l a r e a ( V TA ) .
Furthermore, autoradiography
in Figure B showed reduced
MOR function in the VTA for
animals experiencing pain
compared to controls. The
circled regions indicate the
approximate location of the
VTA, while warmer colors
(orange and red) signify greater
function than cooler colors (light
and dark green). These results
indicate the importance of MOR
function on VTA neurons
projecting to the NAc in DA
release and the effect of
inflammatory pain on this
system.

To test this hypothesis, we bilaterally inserted
cannulae into the VTA, a brain region
containing MORs and involved in reward
processing, of Sprague-Dawley and LongEvans rats of both sexes, Figure A. Complete
Freund’s Adjuvant (CFA) was used to induce
chronic inflammatory pain, Figure C. CTAP, a
highly selective MOR antagonist, was injected
via cannulae to induce withdrawal symptoms,
Figure B. Each animal experienced one of
three conditions: CFA + CTAP, Saline + CTAP,
or CFA + Saline. Wet dog shakes (WDS), a
common sign of opioid withdrawal in rats,
were measured in five minute periods one,
two, three, five, and eight hours after CTAP
injection.
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Desensitization

Binding of an agonist at the MOR inhibits tonic GABA release,
leading to disinhibition of dopaminergic neurons projecting to the
NAc and thus an increase in DA (Figure A). In animals experiencing
inflammatory pain, as in opioid dependent rats, the MORs are
desensitized. We hypothesized that endogenous opioid release in
chronic inflammatory pain may lead to dramatic changes in opioid
sensitivity. We chose to test the appearance of withdrawal signs by
injecting a selective MOR antagonist: CTAP.
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Desensitized MOR
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Why were wet dog shakes used to measure
withdrawal syndrome?
• Well established opioid withdrawal
symptom in rats
• Discrete, can easily quantify withdrawal
• Easy to observe – high inter-observer
reliability
• Long time course for experiment, different
experimenters observed the animals
• Requires no special equipment
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The number of WDS experienced for each treatment group at each observation
time are displayed in Figure A. A two-way ANOVA (treatment X time) revealed a
main effect of treatment
(F₂,₈₀ = 13.11, p < 0.001), no
effect of
(F₄,₈₀ = 0.53, p
Scale-Location
Residuals
vs time
Leverage
22
= 0.72), and no significant
interaction between treatment and time (F₈,₈₀ =
22 0.67, p
= 0.71). These results indicate
the number of WDS depended on treatment,
38 that
57
57
rather than time, and that the effect of treatment did not vary with time. 38
Post-hoc
analysis using a Tukey HSD (honest significant difference) test was run for
pairwise comparisons. The CTAP-CFA group showed a significant increase in the
number of WDS compared to the Sal-CFA group (p < 0.001) and the CTAP-Sal
Cook's distance
group (p < 0.001). Plots of the residuals, in Figure B, demonstrated a good fit of
this model to the
data.
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0.06 around the
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Conclusions

Results
Wet Dog Shakes
in Male Sprague-Dawley Rats
Wet Dog Shakes in Male Sprague-Dawley Rats

Cannula Insertion

A significant increase in WDS was observed for male SpragueDawley rats in the CTAP-CFA group compared to each of the
other conditions. This increase in WDS may be explained by
chronic inflammatory pain causing MOR desensitization in the
same manner as long term exposure to opioids does.
Furthermore, pain-induced MOR desensitization may increase
the likelihood of developing opioid dependence. As opioids,
like morphine and fentanyl, are considered the gold standard
for pain treatment, patients may experience the combined risk
of exposure to an addictive substance and a dysregulated
response to that substance.
More work investigating how pain impacts opioid dependent
dopamine release is necessary and may ultimately lead to
improved pain treatment and decreased opioid dependence.

Future Directions

Acknowledgements

Additional research must be conducted to assess whether chronic pain increases the likelihood of developing opioid dependence. Specifically, self administration experiments
provide a useful model for drug use in humans. Animals in pain can be compared to control animals to show the behavioral differences between these groups. To measure
motivation, rats are trained to press a lever to receive a food or drug reward. For the condition of pain, a decrease in motivation, often determined by the breakpoint in a progressive
ratio schedule, would provide further evidence of decreased DA, as DA is instrumental in motivation and reward. Dose-response exposes the animals to a range of drug doses and
plots the number of injections to show which dose was preferred. A positively shifted dose-response curve for animals in pain would support our finding of MOR desensitization, as
the most rewarding dose was higher than for controls. In escalation, animals are given access to self administer drugs, in this case opioids, over an extended period. A sharp
increase of intake models the development of drug abuse or dependence in humans. If escalation were to occur more quickly for animals in pain, this would indicate an increased
risk of developing opioid dependence.
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